BACM
MRK icon

Blue Arrow Capital Management’s Merck MRK Stock Holding History

Blue Arrow Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,729
Closed -$744K – 162
2014
Q1 		$744K Buy
+13,729
New +$711K 0.11% 89

Other funds holding MRK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Blue Arrow Capital Management's MRK Position: Q2 2014 in Review

Blue Arrow Capital Management sold out of Merck (MRK) in Q2 2014, closing a stake of 13,729 shares — an estimated $744K sold.

Blue Arrow Capital Management first reported a position in MRK in Q1 2014 and held it in 1 quarter. The position peaked at $744K in Q1 2014. 1,621 funds tracked by Wall St. Rank hold MRK as of Q2 2014.

  • Blue Arrow Capital Management reported no remaining Merck position as of Q2 2014 after selling out during the quarter.
  • Blue Arrow Capital Management sold 13,729 Merck shares in Q2 2014, an estimated $744K.
  • Blue Arrow Capital Management first reported a position in Merck in Q1 2014 and held it in 1 quarter.
  • Blue Arrow Capital Management's Merck position peaked at $744K in Q1 2014.
  • 1,621 funds tracked by Wall St. Rank held Merck as of Q2 2014.

Based on Blue Arrow Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.